Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

In the 21st century, that manifests in various ways, including in the sprawling corporations they are at the helm of ... GSK’s first-on-the-market RSV vaccine, which was a triumph for GSK ...

Added Rigdon, “We’re being advised by the union, but the workers are at the helm of the ship and it took very little ... and the rise of concerns about RSV, norovirus, and severe flus. Rigdon noted ...

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

GRAND RAPIDS, Mich. — As respiratory syncytial virus (RSV) cases surge, one family's harrowing experience highlights the importance of prevention. Emily and Joey Spadafore watched helplessly as ...

Unilever said Tuesday that Hein Schumacher is stepping down after less than two years as chief executive of the consumer goods giant. Schumacher will be replaced by CFO Fernando Fernandez, who ...

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

And the CDC and its vaccine advisory panel have taken a go-slow approach with RSV vaccines for older adults, because of an apparent increased risk of developing Guillain-Barré syndrome after ...

Governor Gavin Newsom is facing criticism from LGBTQ+ advocates and Democratic lawmakers after seeming to say he doesn’t support transgender athletes participating in women's sports on his new ...

The California GOP picks a new leader at its annual convention. What to call the Athletics when they start playing in Sacramento. Finally, an update on CapRadio’s civil lawsuit against its ...

The London-listed firm has spent two decades refining its capabilities, running challenge trials for flu, RSV (respiratory syncytial virus), malaria, and Covid-19. As the biopharmaceutical ...